China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 32.35B +2.6% |
| Revenue (ttm) | 299.99B +4.6% |
| Net Income | 4.50B +20.7% |
| EPS | 0.72 +21.3% |
| Shares Out | 6.28B |
| PE Ratio | 7.19 |
| Forward PE | 6.54 |
| Dividend | 0.22 (4.34%) |
| Ex-Dividend Date | Jun 3, 2026 |
| Volume | 8,737,398 |
| Average Volume | 17,216,799 |
| Open | 5.22 |
| Previous Close | 5.22 |
| Day's Range | 5.13 - 5.22 |
| 52-Week Range | 4.34 - 6.53 |
| Beta | -0.37 |
| RSI | 37.34 |
| Earnings Date | Mar 24, 2026 |
About HKG:3320
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovas... [Read more]
Financial Performance
In 2025, HKG:3320's revenue was 269.57 billion, an increase of 4.62% compared to the previous year's 257.67 billion. Earnings were 4.04 billion, an increase of 21.34%.
Financial numbers in CNY Financial StatementsNews
Health product chain store CR Care to close all 19 branches in Hong Kong in November
Health product chain CR Care will close all 19 of its Hong Kong branches next month, citing “external uncertainties” and various “operational challenges.” In a Facebook post shared on Tuesday, the cha...